KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Retained Earnings (2016 - 2025)

Pacira BioSciences (PCRX) has 16 years of Retained Earnings data on record, last reported at -$199.3 million in Q4 2025.

  • For Q4 2025, Retained Earnings fell 58211.37% year-over-year to -$199.3 million; the TTM value through Dec 2025 reached -$199.3 million, down 58211.37%, while the annual FY2025 figure was -$199.3 million, 58211.37% down from the prior year.
  • Retained Earnings reached -$199.3 million in Q4 2025 per PCRX's latest filing, up from -$201.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $1.4 million in Q1 2025 and bottomed at -$243.5 million in Q1 2021.
  • Average Retained Earnings over 5 years is -$111.6 million, with a median of -$134.8 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: plummeted 66733.65% in 2021, then surged 788.82% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$211.9 million in 2021, then skyrocketed by 99.82% to -$380000.0 in 2022, then soared by 165.0% to $247000.0 in 2023, then surged by 38.87% to $343000.0 in 2024, then plummeted by 58211.37% to -$199.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$199.3 million in Q4 2025, -$201.0 million in Q3 2025, and -$206.4 million in Q2 2025.